Filling a prescription for the public's health

Journal of the American Pharmacists Association

Volumn 43, Issue 1, 2003, Pages 13-16

  Babb, John ^a   Babb, Victoria J ^b  

^a Office of Emergency Response   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DRUG SURVEILLANCE PROGRAM; DRUG THERAPY; HUMAN; NOTE; ORGANIZATION AND MANAGEMENT; PHARMACY; PREVENTIVE HEALTH SERVICE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG THERAPY; HUMANS; IMMUNIZATION PROGRAMS; PHARMACEUTICAL SERVICES;

EID: 0037263991     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/10865800360466999     Document Type: Article

References (21)

1. Evans C, Dukes E, Crawford B. The role of pharmacoeconomic information in the formulary decision-making process. J Manage Care Pharm. 2000; 6:108-21.
2. Babb VJ, Babb J. pharmacist involvement in Healthy People 2010. J Am Pharm Assoc. 2003;43:56-60.
3. U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. 2 vols. Washington, DC: U.S. Government Printing Office; 2000.
4. Ciardulli LM, Goode J-V R. Using health observances to promote wellness in community practice. J Am Pharm Assoc. 2003;43:61-8.
5. Rezulin to be withdrawn from the market [news release]. Rockville, Md: U.S. Food and Drug Administration; March 21, 2000.
6. Misbin RI. Troglitazone-associated hepatic failure [letter]. Ann Intern Med. 1999;130(4 pt 1):330.
7. Neuschwander-Tetri BA, Isley WL, Oki JC, et al. Troglitazone-nduced hepatic failure leading to liver transplantation. A case report. Ann Intern Med. 1998;129:1:38-41.
8. Miller JL. Advisory panel hears contradictory evidence, backs keeping troglitazone on market. Am J Health Syst Pharm. 1999;56:840, 842.
9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-5.
10. Adverse Drug Events Reports - Statistics Between June 1993 and June 1999 [unpublished data]. Rockville, Md: AERS Reporting System, Office of Drug Safety, Center for Drug Evaluation and Research; 2001.
11. Shlaes DM, Gerding DN, John JF Jr., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Commission on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis.1997;25:584-99.
12. Interagency Task Force on Antimicrobial Resistance. A Public Health Action Plan to Combat Antimicrobial Resistance - Part I: Domestic Issues. Atlanta, Ga: Centers for Disease Control and Prevention; 2001. Available at: www.cdc. gov/drugresistance/actionplan. Accessed January 29, 2001.
13. Doern GV, Brueggemann AB, Huynh H, Wingert E. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis. 1999;5:757-65.
14. Chesney MA, Ickovics J, Hecht FM, et al. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999; 13(suppl A):S271-8.
15. Kaye KS, Frainow HS, Abrutyn E. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 2000;14:293-319.
16. Grabenstein JD. Low immunization rates in ethnic minorities - a problem pharmacists can help solve. J Am Pharm Assoc. 1999;39:708.
17. Van Amburgh JA, Waite NM, Hobson EH, Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy. 2001;21:115-22.
18. Madhavan SS, Rosenbluth SA, Amonkar M, et al. Pharmacists and immunization: a national survey. J Am Pharm Assoc. 2001;41:32-45.
19. Influenza and pneumococcal vaccination levels among persons aged 65 years - United States, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:1019-24.
20. Recommended Childhood Immunization Schedule- United States, 2002. Atlanta, Ga: National Immunization Program, Centers for Disease Control and Prevention; 2002. Available at: www.cdc.gov/nip/recs/child-schedule.PDF. Accessed December 4, 2002.
21. Satcher D. Influenza and pneumococcal vaccine for adults [press conference]. Washington, DC: National Press Club; October 7, 1999. Available at: www.nfid.org/ pressconfs/flu99/transcript. html. Accessed December 4, 2002.